Duke Kannapolis News

Susanna Naggie Named Director of CTSI

Mary E. Klotman, MD, dean of the Duke University School of Medicine, announced today that Susanna Naggie, MD, MHS, has been named director of the Duke Clinical and Translational Science Institute (CTSI), effective immediately.

Duke Launches Site for COVID Vaccine Study Among Health Care Workers

The Duke Clinical and Translational Science Institute (CTSI) is collaborating with Duke Emergency Medicine on a public health surveillance project dubbed Preventing Emerging Infections Through Vaccine Effectiveness Testing, or PREVENT II. Anyone who works at a Duke Health location and has recently been tested for COVID-19, whether positive or negative for infection, may be eligible to participate.

2022 CTSI Translational Impact Report: Advancing Equity

This Impact Report showcases many of our accomplishments over the past year. We invite you to review these highlights and learn more about Duke CTSI’s contributions to meaningful and equitable health improvement within our communities and beyond.

Duke Kannapolis Data Tool Accelerates Research for Investigators

With just a few clicks, a new data exploration tool developed by the Duke Clinical and Translational Science Institute (CTSI) research site in Kannapolis enables Duke investigators to quickly identify populations of interest, accelerating their research.

President Price Applauds Research, Innovation at Duke Kannapolis Campus

During roundtable discussions with Duke collaborators, local leaders, and study participants, Duke University President Vincent Price spent his historic visit learning more about the unique research facility that has enrolled nearly 14,000 volunteers in dozens of studies using a successful community-engaged research model. Duke Kannapolis is a part of the Duke Clinical and Translational Science Institute (CTSI).